Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this PMS study was to monitor and assess the safety of Mobic® intramuscular injection (7.5mg ~ 15mg, q.d.) up to 3 days (in case of need for prolonged treatment, switch to Mobic® capsule therapy was possible) in Korean patients with osteoarthritis and rheumatoid arthritis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Efficacy assessment by the treating physician | up to 3 day | |
| Combined efficacy, safety and tolerability assessment by the treating physician | up tp 3 day | |
| Incidence of adverse events | up tp 3 day |
Not provided
Not provided
INCLUSION CRITERIA:
diagnosed as osteoarthritis and rheumatoid arthritis
EXCLUSION CRITERIA:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Boehringer Ingelheim Study Coordinator | B.I. Korea Ltd. | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Investigational Site | Busan | South Korea | ||||
| Boehringer Ingelheim Investigational Site |
Not provided
| Daegu |
| South Korea |
| Boehringer Ingelheim Investigational Site | Daejeon | South Korea |
| Boehringer Ingelheim Investigational Site | Gangwondo | South Korea |
| Boehringer Ingelheim Investigational Site | Gwangju | South Korea |
| Boehringer Ingelheim Investigational Site | Gyeongbuk | South Korea |
| Boehringer Ingelheim Investigational Site | Gyeonggido | South Korea |
| Boehringer Ingelheim Investigational Site | Gyeongnam | South Korea |
| Boehringer Ingelheim Investigational Site | Jeonnam | South Korea |
| Boehringer Ingelheim Investigational Site | Seoul | South Korea |
| Boehringer Ingelheim Investigational Site | Taebuk | South Korea |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided